| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TL-1-85 | GDSC1000 | pan-cancer | AAC | 0.003 | 0.9 |
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | -0.0099 | 0.9 |
| mRNA | BRD-K34485477 | CTRPv2 | pan-cancer | AAC | 0.0074 | 0.9 |
| mRNA | KH-CB19 | CTRPv2 | pan-cancer | AAC | 0.0043 | 0.9 |
| mRNA | Cisplatin | GDSC1000 | pan-cancer | AAC | 0.0031 | 0.9 |
| mRNA | Tamoxifen | CTRPv2 | pan-cancer | AAC | -0.0034 | 0.9 |
| mRNA | SN-38 | GDSC1000 | pan-cancer | AAC | 0.0029 | 0.9 |
| mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | 0.0031 | 0.9 |
| mRNA | SB52334 | GDSC1000 | pan-cancer | AAC | -0.0026 | 0.9 |
| mRNA | B02 | CTRPv2 | pan-cancer | AAC | -0.0028 | 0.9 |